In conclusion, CI protected ICH-induced injury by reducing hematoma volume, microglial activation, cofilin rods/aggregates, neuroinflammation, and improved neurobehavioral outcomes following ICH by reducing ER stress-related neuroinflammation subsequently preventing inflammasomes and cell death (Figure 7). The gene discussed is CFL1; the disease is hematoma.